The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex

With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?

Would Pfizer, Roche or Novartis megamerge with BMS? Rumors say they're crunching numbers now

As Trump talks 'America First' on trade, pharma presses its global patent rights

Novartis expands Vivinda TV, offering docs digital access to medical conferences

Gilenya-maker Novartis features more MS patients in new online dictionary tools

If Trump's 'serious' on drug pricing, Sanders says he's willing to pitch in

EMA raises manufacturing questions over Novartis biosimilar production

Trump's pharma CEO confab: Get prices 'way down,' get 'better innovation' and get back to U.S.